Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3060]

What's new on ADCs in management of advanced NSCLC

Dr David Planchard - Institute Gustave Roussy, Villejuif, France

What's new on ADCs in management of advanced NSCLC ( Dr David Planchard - Institute Gustave Roussy, Villejuif, France )

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and...

Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects ( Dr Nata Dieng - Hôpital Principal de Dakar, Dakar, Senegal )

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR...

Dr Thierry André - Sorbonne Université, Paris, France

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC ( Dr Thierry André - Sorbonne Université, Paris, France )

Genetic testing and targeted therapy in Ivory Coast

Dr Safiatou Coulibaly - Institute Pasteur De Côte D'ivoire, Adiopodoumé, Ivory...

Genetic testing and targeted therapy in Ivory Coast ( Dr Safiatou Coulibaly - Institute Pasteur De Côte D'ivoire, Adiopodoumé, Ivory Coast )

Clinical Research Mentorship Program for LMICs

Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada

Clinical Research Mentorship Program for LMICs ( Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada )

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...

Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy ( Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium )

T-DM1 shows promise in treating unresectable locally advanced or metastatic...

Dr Sara Hurvitz - University of Washington, Seattle, USA

T-DM1 shows promise in treating unresectable locally advanced or metastatic HER2-positive breast cancer ( Dr Sara Hurvitz - University of Washington, Seattle, USA )

CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer

Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya

CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer ( Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya )

The quantification of cancer medicines in Zambia

Dr Susan Citonje Msadabwe - Cancer Diseases Hospital, Lusaka, Zambia

The quantification of cancer medicines in Zambia ( Dr Susan Citonje Msadabwe - Cancer Diseases Hospital, Lusaka, Zambia )

ASCO's strategic plan for cancer care in LMICs

Dr Lynn Schuchter - President, American Society of Clinical Oncology (ASCO), USA

ASCO's strategic plan for cancer care in LMICs ( Dr Lynn Schuchter - President, American Society of Clinical Oncology (ASCO), USA )

The past and the present work of AORTIC

Prof Serigne Gueye - Campus Franco-Sénégalais, Dakar, Senegal

The past and the present work of AORTIC ( Prof Serigne Gueye - Campus Franco-Sénégalais, Dakar, Senegal )

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma...

Dr Jonathan Friedberg - University of Rochester, Rochester, USA

Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituximab therapy ( Dr Jonathan Friedberg - University of Rochester, Rochester, USA )

More from ecancer